In this episode of the "For Your Innovation" podcast, Brett Winton and Nemo Marjanovic interview Alex Z, the founder and CEO of Insilico Medicine, about the application of AI in drug discovery and development. Nemo sets the stage by explaining the potential of AI to identify patterns in data and optimize drug design, particularly in the hit-to-lead and lead optimization phases. The discussion covers the promise of AI in reducing the time and cost associated with bringing drugs to market, contrasting Insilico's approach with that of companies like Recursion, and exploring the potential for AI-driven platforms to consolidate the pharmaceutical industry. Alex Z elaborates on Insilico's journey, from its origins as an AI-focused company to its current status as a drug discovery and development platform, discussing the company's approach to model validation and the integration of various AI tools. The conversation further explores the challenges and opportunities in aging research, including the potential for AI to identify targets that can improve quality of life and extend lifespan.
Sign in to continue reading, translating and more.
Continue
